Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial results for the Period Ending on 2026-06-30 ( Six Months )

Jamjoom Pharma reported a 6% year-on-year increase in net profit to SAR 305.8 million for the first half of 2026, with second-quarter revenue accelerating by 12.4% to SAR 445.3 million. Total first-half revenue reached SAR 926.7 million, driven by a recovery in market momentum, higher sales volumes, and a favorable product mix.
Gross profit for 1H 2026 rose 11% to SAR 604.0 million as margins expanded to 65.2%, supported by a shift toward higher-value therapeutic areas and stable raw material costs. EBITDA reached SAR 345.5 million with a 37.3% margin, though gains were partially offset by a 15.7% increase in selling and distribution expenses used to expand the company's field force.
Performance was led by the Cardiometabolic and Ophthalmology segments, which grew 24.5% and 15.8% respectively, while regional revenue from North Africa jumped 35% and the Gulf rose 20%. Sustained cash flow generation and a strong balance sheet enabled the company to increase its interim dividend to SAR 2.2 per share.
Operational efficiency improved as the cash conversion cycle was reduced to 285 days from 305 days, primarily due to better inventory management. Production volume across the comp

Element List	Current Quarter	Similar quarter for previous year	%Change	Previous Quarter	% Change
Sales/Revenue	445.31	396.22	12.389	481.38	-7.493
Gross Profit (Loss)	293.65	250.8	17.085	310.38	-5.39
Operational Profit (Loss)	146	135.35	7.868	172.38	-15.303
Net Profit (Loss) Attributable to Shareholders of the Issuer	137.63	132.02	4.249	168.21	-18.179
Total Comprehensive Income Attributable to Shareholders of the Issuer	148.65	135.27	9.891	152.84	-2.741
All figures are in (Millions) Saudi Arabia, Riyals

Element List	Current Period	Similar period for previous year	%Change
Sales/Revenue	926.7	853.75	8.544
Gross Profit (Loss)	604.03	543.64	11.108
Operational Profit (Loss)	318.37	293.53	8.462
Net Profit (Loss) Attributable to Shareholders of the Issuer	305.84	289.06	5.805
Total Comprehensive Income Attributable to Shareholders of the Issuer	301.49	293.38	2.764
Total Shareholders Equity (after Deducting Minority Equity)	1,878.25	1,681.79	11.681
Profit (Loss) per Share	4.37	4.13
All figures are in (Millions) Saudi Arabia, Riyals

Element List	Amount	Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value	-	-
Accumulated Losses	-	-
All figures are in (Millions) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is	Revenue increased by 12.4% to SAR 445.3 million, driven by higher volumes and a favorable product mix, supported by sustained demand for strategic brands and strong growth in the Gulf, North Africa and other export markets.
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net profit increased by 4.2% to SAR 137.6 million, supported by revenue growth and gross-margin expansion, partly offset by higher operating expenses, lower other income and lower income from joint venture.
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is	Revenue for the current quarter decreased by 7.5% compared to the first quarter of 2026, as the first quarter is typically stronger in terms of revenue due to higher number of deliveries occurring at the start of the year.
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is	Net profit for the current quarter decreased by 18.2% compared to the first quarter of 2026, mainly due to lower revenue and higher selling and distribution expenses resulting from more hiring and promotional activity during the quarter.
The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is	Revenue increased by 8.5% to SAR 926.7 million, driven by higher volumes, favorable product mix across strategic brands and sales growth across key markets.
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is	Net profit increased by 5.8% to SAR 305.8 million, supported by revenue growth and gross-margin expansion, partly offset by higher operating expenses due to increase in commercial hiring and promotional activity, an adverse foreign-exchange impact compared with a gain in the prior-year period and lower share of profit from the Joint Venture.
Statement of the type of external auditor's report	Unmodified conclusion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)	None
Reclassification of Comparison Items	None
Additional Information	Please refer to the attached Earnings Release for more information on the 2Q and H1 2026 results.
Attached Documents	Attached Documents